
Corsica Health Review
Best for: side-by-side compounded and brand-name GLP-1 pricing on one platform
Corsica Health is a telehealth platform offering both compounded GLP-1s and brand-name FDA-approved injections through a structured assessment, provider review, and medication flow. Its differentiator is publishing pricing for compounded and brand SKUs side by side on one site — uncommon transparency. Compounded semaglutide starts at $299/mo and tirzepatide at $399/mo, with brand Ozempic, Wegovy, and Mounjaro at $1,499/mo.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Corsica Health is a solid telehealth option with balanced features and pricing.
Corsica Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Wegovy, Ozempic, Mounjaro
- Starting price
- $199/mo (3-month plan: $597 upfront, 20% off)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Corsica Health
Each dimension is scored algorithmically from Corsica Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.1/10At $199/mo, Corsica Health runs about 18% above the $169 median for GLP-1 providers.
Effectiveness25%
8.7/10Corsica Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
7.7/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.6/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-06).
Accessibility10%
6.4/10Corsica Health's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.2/10Corsica Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Corsica Health review
Last checked 2026-06-06- Confirmed current pricing across 8 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Corsica Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
3-month plan: $597 upfront, 20% off
1-month plan
3-month plan: $747 upfront, 28% off
1-month plan
Ready to get started?
Plans and promotions change often — check Corsica Health's current pricing and active discounts before you decide.
What we like
- Public pricing shown for both compounded and brand-name options — a real transparency advantage
- $1,499/mo brand-name Wegovy/Ozempic/Mounjaro is below typical retail cash-pay
- LegitScript Certified
- Clear 3-step intake: Assessment, Provider Review, Receive Medication
- $199/mo compounded semaglutide and $249/mo compounded tirzepatide (3-month plans) are competitively priced
Watch-outs
- Legal entity name and state of incorporation not disclosed on the site
- Pharmacy partner described only as a 'licensed compounding pharmacy,' not named
- Per-state availability not listed publicly
- First-month promotional pricing not disclosed
- Lab-work inclusion not clearly disclosed
- Brand lineup omits Foundayo (offers Wegovy, Ozempic, Mounjaro and Zepbound)
Corsica Health: the rare provider that shows you compounded and brand prices on the same screen
Most GLP-1 telehealth sites pick a lane. They either sell you a cheaper compounded copy of semaglutide or tirzepatide, or they help you get the brand-name pen — rarely both, and almost never with the prices laid out next to each other. Corsica Health is the unusual exception. It publishes its compounded plans and its brand-name injections side by side on one platform, so you can see exactly what the trade-off costs before you ever fill out an intake form. If you have been bouncing between sites trying to compare a budget compounded plan against the real Wegovy or Mounjaro, this is the provider that lets you do it in one place.
How the pricing actually works
Corsica runs two tracks. On the compounded side, semaglutide starts at $199 a month and tirzepatide is a bit higher — but those are the three-month plan rates, and that detail matters. The headline numbers come from committing upfront: the semaglutide three-month plan bundles the lower per-month price into a single payment with roughly a fifth off, and the tirzepatide three-month plan discounts even more steeply. If you want to pay month to month instead, both drugs cost noticeably more per month. So the advertised price is real, but it assumes you are willing to prepay for a quarter.
The brand-name track is a flat figure across the lineup. Real Ozempic, Wegovy, Mounjaro and Zepbound are all offered at the same monthly rate. That is a high four-figure number — there is no getting around it — but it does land below what these pens typically run at a cash-pay retail pharmacy counter without insurance. For comparison, the category median we track for monthly programs is $169, which tells you the compounded plans here sit in normal competitive territory while the brand option is, predictably, in a different universe of cost.
- Compounded semaglutide — $199/mo on the three-month plan; higher month-to-month
- Compounded tirzepatide — a bit above semaglutide, with an even deeper three-month discount
- Brand Ozempic, Wegovy, Mounjaro, Zepbound — a flat high four-figure monthly rate, below typical retail cash price
- Every plan includes the provider consultation, the medication if prescribed, shipping, and ongoing support
What's included, and what you actually do to get started
Corsica keeps the process to three steps: you complete an online assessment, a licensed provider reviews it, and if you are approved the medication ships to you. There is no separate menu of add-on fees buried in the flow — the company states that plans include a provider consultation, the medication itself when prescribed, free shipping, and ongoing care support. It advertises no-insurance-needed enrollment, free shipping on every order, and cancel-anytime terms. That is a clean, low-friction setup, and the bundled shipping and consult are genuine value rather than a teaser.
The real differentiator: transparency you can verify
Plenty of providers claim to be transparent. Corsica is one of the few that backs it up by publishing every SKU — compounded and brand — openly, and its pricing is consistent enough across its own product data that we could verify five separate prices verbatim. That is meaningfully better than the many telehealth sites that hide the real number behind a quiz. The platform also carries LegitScript certification, an independent verification that the pharmacy operation meets legal and safety standards, which is a reassuring baseline signal for a category full of fly-by-night sellers.
Where Corsica is frustratingly vague
For all its pricing openness, Corsica is oddly quiet about who it actually is. The legal entity name and state of incorporation are not disclosed on the site. The compounding pharmacy that makes your semaglutide or tirzepatide is described only as a 'licensed compounding pharmacy' and is never named — so you cannot independently check that specific pharmacy's accreditation or inspection history the way you can with providers that name their 503A or 503B partner outright. The company lists a New York City contact, but it does not publish which states it can actually ship to, so you will need to confirm your own state is covered during intake.
- Legal entity and state of incorporation are not published
- The compounding pharmacy partner is unnamed
- Per-state availability is not listed — verify your state during signup
- No first-month promotional rate is advertised, so don't expect a teaser discount
- Lab-work requirements aren't clearly spelled out before you enroll
- An internal site inconsistency exists: an FAQ still quotes an older starting price than the live product cards, so treat the lower live price as current and confirm at checkout
Who should choose Corsica — and who should skip it
Corsica is a strong fit if you specifically want to weigh a compounded plan against the real brand pen and make that decision with actual numbers in front of you. It is also reasonable if you want one provider that can serve you either way over time — start compounded to manage cost, switch to brand later if you choose. The bundled shipping, included consult, and LegitScript certification make it a credible mainstream option rather than a bargain-bin one.
Skip it if pharmacy transparency is your top priority. If you want to know exactly which accredited pharmacy is compounding your medication and exactly what corporate entity stands behind the service, Corsica's refusal to name those things is a real strike against it — and there are providers that disclose both. It is also not the move if you need confirmed coverage in your state before committing, since that information simply isn't posted. You can see how we weigh transparency, pricing, and safety in our scoring methodology.
Bottom line
Corsica Health earns its place on the strength of one genuinely uncommon thing: it shows you both the cheap compounded route and the real brand route, openly priced, on a single platform with independent certification behind it. The compounded plans are competitively priced for shoppers willing to prepay a quarter, and the flat brand rate undercuts typical retail cash pricing. The catch is corporate and pharmacy opacity — Corsica tells you the price of everything while staying quiet about who it is and who fills your prescription. If transparent pricing is what you came for, it delivers. If you need to know the name on the pharmacy door, look elsewhere.
Ready to start with Corsica Health?
Starting at $199/month. See current pricing and start your free consultation.
Alternatives to Corsica Health
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Corsica Health review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Corsica Health?
Starting at $199/month. See current pricing and start your free consultation.